ACB $3.620 (-4.99%)

ACNNF $0.189 (1.51%)

AERO $0.920 (3.37%)

AGEEF $0.170 (1.91%)

ALEAF $0.615 (13.49%)

AMMJ $0.230 (3.23%)

APHA $4.980 (-1.78%)

ARNA $47.400 (-1.72%)

ATT:CNX $0.080 (0%)

ATTBF $0.015 (2.07%)

AUSA:CNX $0.590 (1.72%)

AUSAF $0.448 (1.29%)

AVXL $2.470 (-3.89%)

BAMM:CNX $0.970 (2.11%)

BBM:CNX $0.120 (-4%)

BBRRF $0.104 (17.38%)

BE:CNX $0.035 (0%)

BIO:CNX $0.250 (0%)

BLEVF $0.035 (40.53%)

BLO:CNX $0.510 (-3.77%)

BLOZF $0.400 (0.3%)

BUDZ $0.402 (-1.95%)

BXNG $0.448 (-4.27%)

CADMF $0.370 (12.05%)

CALI:CNX $0.125 (8.7%)

CANN $0.620 (5.08%)

CARA $21.180 (2.42%)

CBII:CNX $0.145 (16%)

CBIIF $0.102 (21.2%)

CBWTF $0.582 (4.37%)

CGC $20.470 (-4.61%)

CGRW $0.180 (-10%)

CHOO:CNX $0.220 (-2.22%)

CHOOF $0.171 (0.65%)

CNAB $0.322 (3.9%)

CNBX $0.143 (-4.03%)

CNGGF $0.690 (-11.53%)

CODI $22.315 (0.34%)

CPMD $1.750 (0%)

CRBP $4.585 (1.66%)

CRON $8.520 (7.44%)

CROP:CNX $0.020 (-20%)

CRTPF $2.330 (-6.43%)

CRXPF $0.018 (-0.55%)

CSI:CNX $0.425 (-13.27%)

CTST $1.040 (0%)

CURR $3.250 (9.43%)

CVSI $1.710 (12.87%)

DIGP $0.105 (2.94%)

DXBRF $0.260 (4.42%)

EAPH $0.003 (4%)

EAT:CNX $0.100 (-4.76%)

EEVVF $0.161 (-0.31%)

EMHTF $0.571 (11.53%)

EPWCF $0.038 (0%)

EVIO $0.380 (-2.56%)

FFRMF $0.049 (6.52%)

FFT:CNX $0.060 (-14.29%)

FNNZF $0.085 (0%)

FSDDF $0.041 (0%)

GGTTF $0.154 (8.61%)

GLDFF $0.020 (-13.04%)

GLH:CNX $0.025 (-16.67%)

GLNNF $0.043 (-2.29%)

GNBT $1.200 (-0.83%)

GRIN:CNX $0.125 (0%)

GRWG $4.770 (7.92%)

GSTR:CNX $0.085 (0%)

GTBIF $8.500 (4.94%)

GTII:CNX $11.170 (-0.18%)

GWPH $109.410 (0.34%)

HEXO $2.125 (-9.57%)

HHPHF $0.050 (-12.06%)

HLSPY $0.600 (3%)

HMLSF $8.163 (6.05%)

HMPPF $0.498 (0%)

HRVOF $0.229 (-0.09%)

HSTRF $0.244 (0%)

HUGE:CNX $7.450 (-2.61%)

IAN:CNX $1.930 (0%)

IGC $0.875 (-1.67%)

IGXT $0.615 (-6.12%)

IIPR $81.720 (-4.11%)

IMLFF $0.230 (-3.48%)

INQD $0.003 (-3.13%)

IONC:CNX $0.025 (0%)

IONKF $0.020 (-14.89%)

ISOL:CNX $0.220 (-4.35%)

ISOLF $0.172 (1.09%)

ITHUF $1.468 (8.71%)

IVITF $0.120 (4.15%)

JWCAF $0.290 (-0.17%)

KALTF $0.024 (0%)

KBEV:CNX $0.175 (0%)

KBEVF $0.128 (2.07%)

KHRNF $0.675 (12.05%)

KSHB $1.830 (11.59%)

LHS:CNX $0.500 (-1.96%)

LHSIF $0.390 (5.37%)

LOVE:CNX $0.145 (3.57%)

LXLLF $0.377 (0%)

LXRP $0.620 (-0.02%)

LXX:CNX $0.760 (-6.17%)

MCIG $0.033 (4.76%)

MDCL $3.020 (-0.98%)

MEDIF $4.016 (2.83%)

MGWFF $0.037 (-17.78%)

MICWF $0.124 (2.92%)

MJ:CNX $0.130 (0%)

MJNA $0.029 (16.47%)

MNTR $0.130 (-0.15%)

MRRCF $0.060 (-14.14%)

MWM:CNX $0.150 (-6.25%)

MYM:CNX $0.230 (-8%)

MYMMF $0.187 (3.78%)

NCNNF $0.411 (-0.37%)

NDVAF $0.205 (-7.84%)

NGW:CNX $0.160 (0%)

NRXCF $0.030 (-9.09%)

NSPDF $0.059 (-26.25%)

NTEC $0.671 (0.09%)

NVTQF $0.121 (0%)

NWKRF $0.424 (0%)

NXGWF $0.125 (-1.4%)

NXTTF $0.286 (-0.21%)

OH:CNX $5.300 (6%)

ORHOF $3.770 (3.86%)

OWCP $0.008 (-6.33%)

PHGI:CNX $0.365 (-3.95%)

PHGRF $0.278 (-8.43%)

PHVAF $0.142 (-5.62%)

PILL:CNX $0.500 (0%)

PKG:CNX $0.120 (4.35%)

PLPRF $1.610 (-0.61%)

PLUS:CNX $2.200 (2.33%)

PMCB $0.035 (0%)

PNPL $0.010 (-96.97%)

POTN $0.037 (0.45%)

PRCNF $0.098 (-0.51%)

PTNYF $0.096 (6.44%)

QCA:CNX $0.110 (0%)

RDDTF $0.381 (1.6%)

RLLVF $0.026 (-27.14%)

RMHB $0.035 (-6.91%)

RQB:CNX $0.150 (-6.25%)

RQHTF $0.441 (0.88%)

RVVQF $0.120 (9.09%)

SLNG:CNX $0.510 (-1.92%)

SMG $106.250 (1.54%)

SNN:CNX $1.170 (0%)

SNNVF $0.880 (1.15%)

SOL:CNX $0.435 (-4.4%)

SOLCF $0.340 (0.1%)

SPLIF $0.075 (-6.25%)

SPRWF $0.650 (3.72%)

SRNA $0.071 (1.79%)

STEM:CNX $1.420 (1.43%)

STMH $1.040 (9.47%)

SUN:CNX $0.275 (0%)

TBPMF $0.153 (-1.7%)

TCAN:CNX $0.750 (2.74%)

TCNAF $0.549 (9.8%)

TER:CNX $3.910 (2.89%)

TGEN $2.408 (-2.11%)

TGIF:CNX $0.250 (-1.96%)

TGIFF $0.191 (7.22%)

THC:CNX $0.140 (-3.45%)

THCBF $0.117 (6.36%)

TLRY $23.420 (5.31%)

TOKI:CNX $0.040 (-20%)

TRLFF $0.098 (-24.47%)

TRPX $1.760 (-28.16%)

TRSSF $2.890 (0.7%)

TRTC $0.275 (4.17%)

TURV $0.160 (-7.99%)

VAPN:CNX $0.640 (-4.48%)

VBIO $0.100 (0%)

VIDA:CNX $0.180 (-7.69%)

VIN:CNX $0.065 (0%)

VPRB $0.054 (26.89%)

VRNDF $0.410 (-6.37%)

VRT:CNX $0.250 (-1.96%)

VRTHF $0.193 (13.81%)

VVCIF $0.203 (-3.38%)

WAYL:CNX $0.740 (0%)

WDDMF $0.861 (1.82%)

WLDFF $0.194 (0.83%)

XXII $1.580 (-1.25%)

ZDPY $0.255 (0.02%)

ZYNE $6.430 (-0.31%)

Back

dosist™ Announces Strategic Domestic Expansion Bringing Dose-Controlled Cannabis Products to its Second Adult-Use Market

Nov 6, 2019 • 1:08 PM GMT+0000
2 MIN READ  •  By Anthony Varrell
Share Share - Facebook Share - Twitter

Leading modern wellness company dosist™ today announced the expansion of its national footprint bringing its award-winning proprietary dose-controlled device, the dose pen™, and its targeted formulations to the Nevada market.

dosist™ Announces Strategic Domestic Expansion Bringing Dose-Controlled Cannabis Products 
to its Second Adult-Use Market.

“As a global epicenter for culture, hospitality and tourism, Nevada is rapidly accelerating to become one of the world’s biggest and most intriguing cannabis markets,” said Gunner Winston, CEO of dosist. “With 43 million tourists a year and 3 million residents, Nevada represents an exciting opportunity for dosist to inspire, educate and engage a new audience about the benefits of dose-controlled cannabis therapy.”

Since launch, dosist has been recognized as a disruptor within the health and wellness industry, named by Fast Company as one of 2018’s Top 10 Most Innovative Companies in the health sector and described by Time Magazine as “cannabis that could replace pills” on their 25 Best Inventions of 2016 list.

“We are thrilled to bring our cannabis wellness platform to another key market,” continued Winston. “Our arrival in Nevada further demonstrates our commitment to provide greater access and more choice to a growing group of consumers who are looking to naturally manage their health and happiness.”

dosist’s proprietary dose pen and six targeted formulations including bliss™, sleep™, calm™, relief™, arouse™ and passion™ are now available in Nevada at select premium retailers. Find the full list (here).

About dosist
dosist, based in Los Angeles, California, launched in 2016 and has since been recognized as a disruptor in the health and wellness industry, named by Fast Company as one of 2018’s Top 10 Most Innovative Companies in the health sector, and most recently recognized by LinkedIn as the number two Top Startups 2019: Hottest U.S. Companies To Work For Now. Through its six targeted formulations of the active ingredients in cannabis – bliss™, sleep™, calm™, relief™, passion™ and arouse™ – dosist provides natural alternatives for some of our most common ailments. Their proprietary medical-grade dose pen™and their newly released dose dial™, deliver a precise dose each and every time ensuring a customer has a consistent and repeatable experience. For more information about dosist and our products visit our website at dosist.com and follow us on Facebook, Instagram and Twitter.

For inquiries, please contact The Communications Store:
press@dosist.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/dosist-announces-strategic-domestic-expansion-bringing-dose-controlled-cannabis-products-to-its-second-adult-use-market-300952405.html

SOURCE dosist

 

Source: PR Newswire (November 6, 2019 – 8:00 AM EST)

News by QuoteMedia
www.quotemedia.com

Share Share - Facebook Share - Twitter

Tags

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Technical420 newsletter.

 All good -- no spamming here.